Good evening :)
Switch to

Venus Remedies Ltd

VENUSREM
Health CarePharmaceuticals
MicrocapWith a market cap of ₹31 cr, stock is ranked 1,464
High RiskStock is 5.35x as volatile as Nifty
25.550.40 (+1.59%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Insufficient data

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Stock has not been able to generate better return on equity than bank FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Stock doesn't offer attractive dividend returns

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

Good time to consider, as stock is not in overbought zone

Red Flags Found
ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list, with high pledged promoter holding or high default probability should be handled with caution

Too much promoter holding pledged and high default probability

Health CarePharmaceuticals
MicrocapWith a market cap of ₹31 cr, stock is ranked 1,464
High RiskStock is 5.35x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-1.10
PB RatioPB Ratio
0.09
Dividend YieldDiv. Yield
Sector PESector PE
27.18
Sector PBSector PB
3.01
Sector Div YldSctr Div Yld
0.77%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2016201720182019418.26400.04372.41321.891.69-17.08-30.69-28.57
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Financial Result Updates
Announced OnNov 12, 2019

Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019. | Download

Venus Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019. | Download

Outcome of Board Meeting
Announced OnNov 12, 2019

Venus Remedies Limited has informed the Exchange regarding Board meeting held on November 12, 2019. | Download

Venus Remedies Limited has informed the Exchange regarding Board meeting held on November 12, 2019. | Download

Cash Dividend
Ex. DateSep 20, 2012

Final • Div/Share: ₹ 3

See all events

Tickertape provides data, information & content for Indian stocks, ETFs & indices.

Data powered byPrices shown are delayed by 15 minutes© Tickertape 2019